Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together

Author(s):  McElhiney Linda F

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Abstract:  With the development of new treatment options and reported side effects with the use of silver nitrate ophthalmic solution, the drug manufacturers discontinued production of the silver nitrate ophthalmic solution in the mid 1990s. On December 9, 2009, the U.S. Food and Drug Administration announced that the erythromycin ophthalmic ointment 1-gram tubes were commercially available again and production by the manufacturer was expected to meet the historical demands. Hospitals could expect to replenish their inventory reserves after the first quarter of 2010. However, manufacturer backorders have been increasing due to a variety of factors. If a hospital has a compounding laboratory, it is possible to prepare erythromycin ophthalmic ointment according to the United States Pharmacopeia Chapter <797> standards. Since the commercial product has been available for decades without any major shortages until 2009, there isn’t any published compounding information on how to prepare the ointment. This article discusses t

Related Keywords: Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, gonococcal ophthalmia neonatorum, neonatal blindness, newborns, erythromycin ophthalmic ointment, prophylaxis, drug shortage, treatment alternatives, topical antibiotic, intraocular antimicrobial, ocular administration, eye infection, formulation

Related Categories: FORMULATIONS, OPHTHALMICS, PEDIATRICS, STERILE PREPARATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F Jul/Aug 2010 270-274 Buy
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A Jan/Feb 2003 10-15 View Sample
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D Jul/Aug 2004 269-274 Buy
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin Sep/Oct 2015 357-365 Buy
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr Nov/Dec 2016 495-500 Buy
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease McElhiney Linda F May/Jun 2012 190-195 Buy
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F Sep/Oct 2013 380-383 Buy
Sensitization Therapy for Warts Kuntz Rachael Jul/Aug 2003 266-270 Buy
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F Jul/Aug 2020 287-295 Buy
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Allen Loyd V Jr May/Jun 2016 228 Buy